Back

What Urine Measures Is Not What Tissue Encodes: Compartment-Specific miRNA Coordination in Prostate Cancer

Singh, S.; Biswas, P.; Jain, G.; Trivedi, S.; Yadav, M.; Gupta, M.; Kumar, L.; Singh, Y.; Kumar, U.; Das, P.

2026-06-17 oncology
10.64898/2026.06.14.26355623 medRxiv
Show abstract

Abstract Background Prostate cancer (PCa) diagnosis remains challenged by the limited specificity of prostate-specific antigen (PSA) testing, which cannot reliably distinguish malignancy from benign prostatic hyperplasia (BPH). MicroRNAs (miRNAs) are emerging candidates for liquid biopsy-based diagnostics, but most studies assess expression in isolation within a single compartment (biological source - Tissue, blood, serum, urine etc.), overlooking both compartment-specific behavior and the coordinated relationships among miRNAs. Methods We profiled four candidate miRNAs --- miR-19b-3p, miR-21-5p, miR-101-3p and miR-375-3p, across four biological compartments (prostate tumor tissue, urine, serum, and blood) in 179 patients undergoing prostate biopsy for clinical suspicion of PCa (104 PCa, 75 BPH) using qRT-PCR. Urinary exosomal RNA was isolated with a commercial exosome isolation kit so from here onwards this compartment will be referred to as urine. Differential expression was quantified using Cohen's d; inter-miRNA coordination was assessed via Spearman correlation and differential correlation ({delta} r) analysis; and a compartment-level network rewiring score was derived as the sum of {delta} r| across miRNA pairs. Cross-compartment structural alignment was evaluated by comparing correlation patterns at the population level. Diagnostic models combining PSA, age, and urinary exosomal-miRNA features were evaluated using Logistic Regression, Elastic Net Logistic Regression and Naive Bayes classifiers under leave-one-out cross-validation (LOOCV). Results Effect sizes were largest and most consistent in urine, with miR-101-3p showing the strongest separation between PCa and BPH (d = -1.01), followed by miR-21-5p (d {approx}-0.72$) and miR-19b-3p (d {approx}-0.64). Two markers (miR-19b-3p, miR-375-3p) showed directional reversals across compartments, indicating that disease-associated signals are compartment-specific rather than uniformly conserved. In tumor tissue, PCa was associated with substantial reorganization of inter-miRNA coordination (network rewiring score = 2.46), including the emergence of a strong miR-21-5p--miR-375-3p co-regulatory axis ({delta} r = +0.87$) and decoupling of the miR-21-5p--miR-19b-3p relationship ({delta}r = -0.64$). Urine showed a structurally distinct coordination pattern (rewiring score = 1.77), dominated by a miR-101-3p--miR-19b-3p axis (r = +0.56) absent from tissue; cross-compartment comparison showed concordance in only 1 of 5 miRNA pairs, indicating that urine's architecture is largely independent of tissue's. For diagnostic translation, the conventional PSA cutoff (4 ng/mL) achieved 100% sensitivity but only 23.5% specificity. In urine, miR-101-3p performs better than other miRNAs, with AUC of 0.77 (95% CI: 0.62--0.90). Adding PSA and age to the urinary miR-101-3p further improved discrimination to an AUC of 0.91 (95% CI: 0.82--0.99), with 70% specificity at 92% sensitivity; this pattern was consistent across Elastic Net and Logistic Regression classifiers. Expanding the model to include all urinary miRNAs, age, and pair-derived coordination features did not improve on this result (AUC = 0.88), indicating that population-level coordination changes did not translate into additional individual-level diagnostic value in this cohort. Conclusions miRNA signals in extracellular compartments do not represent direct surrogates of tumor-level molecular architecture; each compartment harbors a distinct, transformed coordination structure reflecting its biological context. While these coordination-level changes are mechanistically informative, the most direct translational gain in this study came from a parsimonious model combining PSA, age with a single urinary marker, miR-101-3p, which improved AUC from 0.77 to 0.91, with specificity 70.5% at 90% sensitivity criteria. This combination represents a promising, interpretable candidate for reducing unnecessary prostate biopsies, pending validation in larger, independent cohorts. Keywords: MicroRNA, Compartment-Specific Biomarkers, Urinary Exosomes, Differential Correlation, Liquid Biopsy, Machine learning, PSA, Early diagnosis

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
Scientific Reports
3612 papers in training set
Top 5%
9.8%
2
British Journal of Cancer
49 papers in training set
Top 0.1%
6.7%
3
Cancers
213 papers in training set
Top 0.9%
6.3%
4
Communications Medicine
113 papers in training set
Top 0.5%
5.2%
5
Frontiers in Oncology
103 papers in training set
Top 0.7%
4.8%
6
PeerJ
308 papers in training set
Top 1%
4.3%
7
The Prostate
11 papers in training set
Top 0.1%
4.0%
8
PLOS ONE
5266 papers in training set
Top 34%
4.0%
9
Biology
45 papers in training set
Top 0.1%
3.2%
10
iScience
1154 papers in training set
Top 7%
3.2%
50% of probability mass above
11
International Journal of Molecular Sciences
494 papers in training set
Top 4%
2.8%
12
Journal of Translational Medicine
57 papers in training set
Top 0.3%
2.7%
13
Clinical Cancer Research
64 papers in training set
Top 0.8%
2.4%
14
Frontiers in Bioinformatics
49 papers in training set
Top 0.3%
2.1%
15
International Journal of Cancer
49 papers in training set
Top 0.5%
2.1%
16
eLife
5828 papers in training set
Top 44%
2.1%
17
Frontiers in Genetics
230 papers in training set
Top 3%
1.7%
18
Briefings in Bioinformatics
354 papers in training set
Top 5%
1.7%
19
Cell Reports Medicine
153 papers in training set
Top 3%
1.4%
20
Endocrinology
43 papers in training set
Top 0.5%
1.4%
21
eBioMedicine
183 papers in training set
Top 3%
1.3%
22
Nature Communications
5641 papers in training set
Top 51%
1.1%
23
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 35%
1.1%
24
npj Digital Medicine
118 papers in training set
Top 3%
1.1%
25
Cancer Medicine
26 papers in training set
Top 0.9%
1.0%
26
Molecular & Cellular Proteomics
25 papers in training set
Top 0.3%
0.8%
27
PLOS Genetics
862 papers in training set
Top 12%
0.8%
28
Molecular Systems Biology
162 papers in training set
Top 3%
0.8%
29
International Journal of Radiation Oncology*Biology*Physics
25 papers in training set
Top 0.4%
0.8%
30
The Journal of Pathology
26 papers in training set
Top 0.8%
0.8%